Abstract
The positive inotropic actions of the cardiotonic steroids and their glycosides can be distinguished from those of other positive inotropic agents, such as catecholamines or xanthine derivatives (see Chap. 10 and 11). The differences in the inotropic actions of these substances suggest differences in their mechanisms of action. Several substances, however, possess positive inotropic properties similar to those of cardiac glycosides. Comparative studies on these glycosides and aglycones indicate strict structural requirements for their cardiotonic actions (see Chap. 2). Considering that only a slight modification of the chemical structure results in a marked reduction in the inotropic potency, it is quite remarkable that substances of different chemical structure (Fig. 1) exhibit positive inotropic actions quite similar to those of cardiac glycosides. Some of these compounds inhibit, as does digitalis, cardiac Na+, K+-ATPase or the sodium pump, whereas others have no direct effect on this enzyme system. The relationships between effects of these substances on Na+, K+-ATPase activity, sodium pump activity, or transmembrane sodium fluxes and the force of myocardial contraction merit consideration.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akera, T.: Quantitative aspects of the interaction between ouabain and (Na+, K+)-activated ATPase in vitro. Biochim. Biophys. Acta 249, 53–62 (1971)
Akera, T.: Membrane adenosinetriphosphatase: A digitalis receptor? Science 198, 569–574 (1977)
Akera, T., Brody, T.M.: Inhibition of brain sodium-and potassium-stimulated adenosine triphosphatase activity by chlorpromazine free radical. Mol. Pharmacol. 4, 600–612 (1968)
Akera, T., Brody, T.M.: The interaction between chlorpromazine free radical and microsomal sodium-and potassium-activated adenosine triphosphatase from rat brain. Mol. Pharmacol. 5, 605–614 (1969)
Akera, T., Brody, T.M.: Inhibitory sites on sodium-and potassium-activated adenosine triphosphatase for chlorpromazine free radical and ouabain. Mol. Pharmacol. 6, 557–566 (1970)
Akera, T., Ku, D.D., Brody, T.M.: Alterations of ion movements as a mechanism of drug-induced arrhythmias and inotropic responses. In: Taurine, Huxtable, R., Barbeau, A. (eds.) pp. 121–134, New York: Raven Press 1976a
Akera, T., Ku, D.D., Frank, M., Brody, T.M., Iwasa, J.: Effects of grayanotoxin I on cardiac Na+, K+ -adenosine triphosphatase activity, transmembrane potential, and myocardial contractile force. J. Pharmacol. Exp. Ther. 199, 247–254 (1976b)
Akera, T., Ku, D.D., Brody, T.M., Manian, A.A.: Inotropic action of hydroxylated chlorpromazine metabolites and related compounds. Biochem. Pharmacol. 27, 995–998 (1978)
Akera, T., Takeda, K., Yamamoto, S., Brody, T.M.: Effects of vanadate on Na, K-ATPase and on the force of contraction in guinea-pig hearts. Life Sci. 25, 1803–1812 (1979)
Albers, R.W., Koval, G.J., Siegel, G.J.: Studies on the interaction of ouabain and other cardioactive steroids with sodium-potassium activated adenosine triphosphatase. Mol. Pharmacol. 4, 324–336 (1968)
Albuquerque, E.X., Seyama, I., Narahashi, T.: Characterization of batrachotoxin-induced depolarization of the squid giant axons. J. Pharmacol. Exp. Ther. 184, 308–314 (1973)
Aski, A., Rao, S.N.: Drugs affecting sodium transport in human erythrocyte ghosts. J. Pharmacol. Exp. Ther. 172, 211–223 (1970)
Badura, H.O.: Die Wirkung des Prednisolonbisguanylhydrazons auf die Kontraktionskraft des Skeletmuskels. Dissertation, Düsseldorf 1966
Banerjee, S.P., Khanna, V.K., Sen, A.K.: Inhibition of sodium-and potassium-dependent adenosine triphosphatase by ethacrynic acid: Two modes of action. Mol. Pharmacol. 6, 680–690 (1970)
Banerjee, S.P., Khanna, V.K., Sen, A.K.: Inhibition of sodium-and potassium-dependent adenosine triphosphatase by ethacrynic acid: Ligand-induced modifications. Biochem. Pharmacol. 20, 1649–1660 (1971)
Barrett, A.M., Cullum, V.A.: The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias. Brit. J. Pharmacol. 34, 43–55 (1968)
Beauge, L.A., Glynn, I.M.: A modifier of (Na+ +K+)-ATPase in commercial ATP. Nature (Lond.) 268, 355–356 (1977)
Beauge, L.A., Glynn, I.M.: Commerical ATP containing traces of vanadate alters response of (Na++K+)-ATPase to external potassium. Nature (Lond.) 272, 551–552 (1978)
Benforado, J.M.: Studies on veratrum alkaloids. XXVI. Comparison of the cardiac action of various tertiary amine ester alkaloids. J. Pharmacol. Exp. Ther. 120, 412–425 (1957)
Benforado, J.M.: The veratrum alkaloids. In: Physiological Pharmacology, Root, W.S., Hoffmann, F.G. (eds.), 2 ed., Vol. 4, part D., pp. 331–398. New York: Academic Press 1968
Bennett, D., Chenoweth, M.B.: Metabolism associated with positive inotropic action. Fed. Proc. 10, 280 (1951)
Bennett, D.R., Andersen, K.S., Andersen, M.V., jr., Robertson, D.N., Chenoweth, M.B.: Structure-activity analysis of the positive inotropic action of conjugated carbonyl compounds on the cat papillary muscle. J. Pharmacol. Exp. Ther. 122, 489–498 (1958)
Besch, H.R.; jr., Watanabe, A.M.: Binding and effect of tritiated quinidine on cardiac subcellular enzyme systems: Sarcoplasmic reticulum vesicles, mitochondria, and Na+,K+-adenosine triphosphatase. J. Pharmacol. Exp. Ther. 202, 354–364 (1977)
Blostein, R., Burt, V.K.: Interaction of N-ethylmaleimide and Ca2+ with human erythrocyte membrane ATPase. Biochim. Biophys. Acta 241, 68–74 (1971)
Bonting, S.L., Hawkins, N.M., Canady, M.R.: Studies of sodium-potassium activated adenosine triphosphatase. VII. Inhibition by erythrophleum alkaloids. Biochem. Pharmacol. 13, 13–22 (1964)
Borchard, U., Fox, A.A.L., Greeff, K.: Positive inotropic and antiarrhythmic actions of the Na+,K+-ATPase inhibitor, isoquinoline derivative, BIIA. Naunyn-Schmiedebergs Arch. Pharmacol. 312, 187–192 (1980)
Borchard, U., Fox, A.A.L., Greeff, K., Schlieper, P.: Negative and positive inotropic action of vanadate on atrial and ventricular myocardium. Nature (Lond.) 279, 339–341 (1979)
Britten, J.S., Blank, M.: Thallium activation of the (Na+-K+)-activated ATPase of rabbit kidney. Biochim. Biophys. Acta 159, 160–166 (1968)
Brody, T.M., Akera, T., Baskin, S.I., Gubitz, R.H., Lee, C.Y.: Interaction of Na, K-ATPase with chlorpromazine free radical and related compounds. Ann. N.Y. Acad. Sci. 242, 527–542 (1974)
Broekjuysen, J., Clinet, M., Delisee, C.: Action of amidarone on guinea pig heart sodium and potassium activated adenosine triphosphatase: Comparison with ouabain. Biochem. Pharmacol. 21, 2951–2960 (1972)
Cantley, L.C., jr., Josephson, L., Warner, R., Yanagisawa, M., Lechene, C., Guidotti, G.: Vanadate is a potent (Na, K)-ATPase inhibitor found in ATP derived from muscle. J. Biol. Chem. 252, 7421–7423 (1977)
Cantley, L.C., Ferguson, J.H., Kustin, K.: Norepinephrine complexes and reduces vanadium (V) to reverse vanadate inhibition of the (Na, K)-ATPase. J. Am. Chem. Soc. 100, 5210–5212 (1978a)
Cantley, L.C., Resh, M.D., Guidotti, G.: Vanadate inhibits red-cell (Na++K+)-ATPase from cytoplasmic side. Nature (Lond.) 272, 552–554 (1978b)
Charlier, R.: Cordarone. In: Handbook of Exper. Pharmacol. 31, 255–288 (1971)
Charnock, J.S., Potter, H.A., McKee, D.: Ethacrynic acid inhibition of (Na++K+)-activated adenosine triphosphatase. Biochem. Pharmacol. 19, 1637–1641 (1970)
Charnock, J.S., Doty, D.M., Russell, J.C.: The effect of temperature on the activity of (Na++K+)-ATPase. Arch. Biochem. Biophys. 142, 633–637 (1971)
Chenoweth, M.B., Pengsritong, K.: Positive inotropic and other actions of fluoroacetate. Fed. Proc. 9, 263 (1950)
Coraboeuf, E., Deroubaix, E., Tazieff-Depierre, F.: Effect of Toxin II isolated from scorpion venom on action potential and contraction of mammalian heart. J. Mol. Cell. Cardiol. 7, 643–653 (1975)
Cotten, M. deV., Maling, H.M., Moran, N.C.: Comparison of the direct and indirect effects of andromedotoxin on the contractile force of the heart. J. Pharmacol. Exp. Ther. 118, 55–62 (1956)
Covin, J.M., Berman, D.A.: Metabolic aspects of the positive inotropic action of fluoride on rat ventricle. J. Pharmacol. Exp. Ther. 125, 137–141 (1959)
Dahl, D.R.: Short chain fatty acid inhibition of rat brain Na-K adenosine triphosphatase. J. Neurochem. 15, 815–820 (1968)
Davis, P.W.: Inhibition of renal Na+, K+-activated adenosine triphosphatase activity by ethacrynic acid. Biochem. Pharmacol. 19, 1983–1989 (1970)
Davis, P.W., Brody, T.M.: Inhibition of Na K -activated adenosine triphosphatase activity in rat brain by substituted phenothiazines. Biochem. Pharmacol. 15, 703–710 (1966)
Donaldson, J., St-Pierre, T., Minnich, J., Barbeau, A.: Seizures in rats associated with divalent cation inhibition of Na+-K+-ATPase. Can. J. Biochem. 49, 1217–1224 (1971)
Dransfeld, H., Greeff, K.: Der Einfluß des Prednison-und Prednisolonbisguanylhydrazons auf die Na++K+-stimulierte Membran-ATPase des Meerschweinchenherzens. Naunyn-Schmiedebergs Arch. Pharmakol. 249, 425–431 (1964)
Dransfeld, H., Galetke, E., Greeff, K.: Die Wirkung des Prednisolonbisguanylhydrazons auf die Na++ K+ -aktivierte Membran-ATPase des Herz-und Skeletmuskels. Arch. Int. Pharmacodyn. 166, 342–349 (1967)
Duggan, D.E., Noll, R.M.: Effects of ethacrynic acid and cardiac glycosides upon a membrane adenosine triphosphatase of renal cortex. Arch. Biochem. Biophys. 109, 388–396 (1965)
Ehmer, A., Jahr, K., Kuschinsky, G., Ullmann, H., Reuter, H., Woller, U.: Über die Herzglykosid-artige Wirkung von Progesteronbisguanylhydrazon (Progesteronbiguazon). Naunyn-Schmiedebergs Arch. Pharmakol. 248, 521–539 (1964)
Epstein, F.H., Whittam, R.: Mode of inhibition by calcium of cell-membrane adenosine-triphosphatase activity. Biochem. J. 99, 232–238 (1966)
Fahn, S., Hurley, M.R., Koval, G.J., Albers, R.W.: Sodium-potassium-activated adenosine triphosphatase of electrophorus electric organ. II. Effects of N-ethylmaleimide and other sulfhydryl reagents. J. Biol. Chem. 241, 1890–1895 (1966)
Fox, A.A.L.: Charakterisierung des Wirkungsmechanismus von Hemmstoffen der Na++K+-aktivierbaren, Mg2+-abhängigen adenosine triphosphatase. Dissertation, Düsseldorf 1979
Fox, A.A.L., Borchard, U., Greeff, K.: Digitalisähnliche and antiarrhythmische Wirkung des Isochinolinderivates BIIA. Z. Kardiol. 68, 244 (1979)
Fox, A.A.L., Greeff, K.: Mechanism of inhibition of sodium-and potassium-dependent adenosine triphosphatase by the isoquinoline derivate BIIA: A specific interaction with sodium activation. Biochem. Pharmacol. 30, 611–617 (1981)
Frank, M., Flom, L.L.: Effects of 2,4,6-triaminopyridine on the electromechanical properties of guinea-pig myocardium. J. Pharmacol. Exp. Ther. 204, 175–182 (1978)
Fricke, U.: Neuere Erkenntnisse über den Wirkungsmechanismus der Herzglykoside. Fortschr. Med. 94, 1839–1845 (1976)
Fricke, U.: Myocardial activity of inhibitors of the Na+-K+-ATPase: Differences in the mode of action and subcellular distribution pattern of N-ethylmaleimide and ouabain. Naunyn-Schmiedebergs Arch. Pharmacol. 303, 197–204 (1978)
From, A.H.L.: N-ethylmaleimide (NEM) induced inotropism. Clin. Res. 18, 306 (1970)
From, A.H.L., Probstfield, J.: P-Chloromercuribenzene sulfonic acid induced inotropism. Fed. Proc. 30, 632 (1971)
From, A.H., Probstfield, J.L., Smith, T.R.: Ethacrynic acid induced inotropism. Proc. Soc. Exp. Biol. Med. 149, 1059–1062 (1975)
Fujita, M., Nagano, K., Mizuno, N., Tashima, Y., Nakao, T., Nakao, M.: Comparison of some minor activities accompanying a preparation of sodium-plus-potassium ion-stimulated adenosine triphosphatase from pig brain. Biochem. J. 106, 113–121 (1968)
Gehring, P.J., Hammond, P.B.: The interrelationship between thallium and potassium in animals. J. Pharmacol. Exp. Ther. 155, 187–201 (1967)
Glitsch, H.G., Reuter, H., Scholz, H.: The effect of the internal sodium concentration on calcium fluxes in isolated guinea-pig auricles. J. Physiol. (Lond.) 209, 25–43 (1970)
Glynn, I.M.: “Transport adenosinetriphosphatase” in electric organ. The relation between ion transport and oxidative phosphorylation. J. Physiol. (Lond.) 169, 452–465 (1963)
Gosalvez, M., Van Rossum, G.D.V., Blanco, M.F.: Inhibition of sodium-potassium-activated adenosine 5’-triphosphatase and ion transport by adriamycin. Cancer Res. 39, 257–261 (1979)
Greeff, K., Schlieper, E.: Artspezifische Wirkungsunterschiede des k-Strophanthins und Prednisolonbisguanylhydrazons: Untersuchungen an isolierten Vorhofpräparaten und Erythrocyten des Menschen, Meerschweinchens, Kaninchens und der Ratte. Arch. Int. Pharmacodyn. 166, 350–361 (1967)
Greeff, K., Meng, K., Schwarzmann, D.: Digitalisähnliche Eigenschaften des Prednisonund Prednisolonbisguanylhydrazons: Ihre Wirkung auf die Kaliumbilanz isolierter Herzpräparate und den Na/K-transport an Erythrocyten. Naunyn-Schmiedebergs Arch. Pharmakol. 249, 416–424 (1964)
Grupp, G., Grupp, I., Johnson, C.L., Schwartz, A.: Effects of vanadate and ouabain on contractile force of rat, guinea pig, rabbit, and cat atria and ventricles. Fed. Proc. 38, 1042 (1979a)
Grupp, G., Grupp, I., Johnson, C.L., Wallick, E.T., Schwartz, A.: Effects of vanadate on cardiac contraction and adenylate cyclase. Biochem. Biophys. Res. Commun. 88, 440–447 (1979b)
Gutman, Y., Hochman, S., Wald, H.: The differential effect of Li+ on microsomal ATPase in cortex, medulla, and papilla of the rat kidney. Biochim. Biophys. Acta 298, 284–290 (1973)
Hackbarth, I., Schmitz, W., Scholz, H., Erdmann, E., Krawietz, W., Philipp, G.: Positive inotropism of vanadate in cat papillary muscle. Nature (Lond.) 275, 67 (1978)
Halbach, S.: Effect of mercuric chloride on contractility and transmembrane potential of the guinea-pig myocardium. Naunyn-Schmiedebergs Arch. Pharmacol. 289, 137–148 (1975)
Han, C.S., Tobin, T., Akera, T., Brody, T.M.: Effects of alkali metal cations on phosphoenzyme levels and (3H)-ouabain binding to (Na++K+)-ATPase. Biochim. Biophys. Acta 429, 993–1005 (1976)
Herrera, F.C.: The role of the active and passive sodium pathways in the mechanism of action of ethacrynic acid. Gen. Pharmacol. 6, 201–207 (1975)
Hexum, T.D.: Studies on reaction catalyzed by transport (Na, K) adenosine triphosphatase. I. Effects of divalent metals. Biochem. Pharmacol. 23, 3441–3447 (1974)
Hogan, P.M., Albuquerque, E.X.: The pharmacology of batrachotoxin. III. Effect on the heart Purkinje fibers. J. Pharmacol. Exp. Ther. 176, 529–537 (1971)
Honerjäger, P., Reiter, M.: The relation between the effects of veratridine on action potential and contraction in mammalian ventricular myocardium. Naunyn-Schmiedebergs Arch. Pharmacol. 289, 1–28 (1975)
Honerjäger, P., Reiter, M.: Sarcolemmal sodium permeability and contractile force of guinea pig papillary muscle. Effects of germitrine. Circ. Res. 40, 90–98 (1977a)
Honerjäger, P., Reiter, M.: The cardiotoxic effect of batrachotoxin. Naunyn-Schmiedebergs Arch. Pharmacol. 299, 239–252 (1977b)
Hopkins, L.L., jr., Mohr, H.E.: Vanadium as an essential nutrient. Fed. Proc. 33, 1773–1775 (1974)
Horackova, M., Vassort, G.: Excitation-contraction coupling in frog heart: Effect of vera-trine. Pflügers Arch. Eur. J. Physiol. 352, 291–302 (1974)
Hudgins, P.M., Bond, G.H.: (Mg2++K+)-dependent inhibition of NaK-ATPase due to a contaminant in equine muscle ATP. Biochem. Biophys. Res. Commun. 77, 1024–1029 (1977)
Hudgins, P.M., Bond, G.H.: Reversal of vanadate inhibition of Na, K-ATPase by catecholamines. Res. Commun. Chem. Pathol. Pharmacol. 23, 313–326 (1979)
Jacob, H.S., Jandel, J.H.: Effects of sulfhydryl inhibition on red blood cells. I. Mechanism of hemolysis. J. Clin. Invest. 41, 779–792 (1962)
Järnefelt, J.: Properties and possible mechanism of the Na+ and K+-stimulated microsomal adenosine triphosphatase. Biochim. Biophys. Acta 59, 643–654 (1962)
Jean, D.H., Bader, H.: Activation and inhibition of (Na++K+)-ATPase by N-ethylmaleimide. Biochim. Biophys. Acta 212, 198–200 (1970)
Jöbsis, F.F., Vreman, H.J.: Inhibition of a Na+ and K+-stimulated adenosine triphosphatase by oligomycin. Biochim. Biophys. Acta 73, 346–348 (1963)
Judah, J.D., Ahmed, K.: Inhibitors of transport and cation activated ATPase. J. Cell. Comp. Physiol. 64, 355–361 (1964)
Kahn, J.B., jr.: Effects of two erythrophleum alkaloids on potassium transfer in human erythrocytes. Proc. Soc. Exp. Biol. Med. 110, 412–414 (1962)
Kahn, J.B., jr., Van Atta, R.A., jr., Johnson, G.L.: Some effects of cassaine on cardiovascular dynamics in the dog. J. Pharmacol. Exp. Ther. 142, 215–222 (1963)
Katzung, B., Rosin, H., Scheider, F.: Frequency-force relationship in the rabbit auricle and its modification by some metabolic inhibitors. J. Pharmacol. Exp. Ther. 120, 324–333 (1957)
Kennedy, K.G., Nayler, W.G.: The effect of quinidine on the activity of a sodium-potassium activated, magnesium-dependent ATPase enzyme isolated from toad cardiac muscle. Biochim. Biophys. Acta 110, 174–180 (1965)
Kobayashi, T., Nakayama, R., Takatani, O., Kimura, K.: Positive chronotropic and inotropic actions of new antitumor agent adriamycin and its cardiotoxicity. Its special references to myocardial contractile force and the change of the transmembrane action potential. Jpn. Circ. J. 36, 259–265 (1972)
Korth, M., Weger, N., Reiter, M.: The positive inotropic action of sodium fluoroacetate on guinea-pig ventricular myocardium. Naunyn-Schmiedebergs Arch. Pharmacol. 303, 714 (1978)
Krayer, O., Acheson, G.H.: The pharmacology of the veratrum alkaloids. Physiol. Rev. 26, 383–446 (1946)
Kroneberg, G., Stoepel, K.: Synthetische Verbindungen mit Digitaliswirkung. NaunynSchmiedebergs Arch. Pharmakol. 249, 393–415 (1964)
Ku, D., Akera, T., Tobin, T., Brody, T.M.: Effects of rubidium on cardiac tissue: Inhibition of Na+, K+-ATPase and stimulation of contractile force. Res. Comm. Chem. Path. Pharmacol. 9, 431–440 (1974)
Ku, D., Akera, T., Tobin, T., Brody, T.M.: Effects of monovalent cations on cardiac Na+, K+-ATPase activity and on contractile force. Naunyn-Schmiedebergs Arch. Pharmacol. 290, 113–131 (1975)
Ku, D.D., Akera, T., Tobin, T., Brody, T.M.: Comparative species studies on the effect of monovalent cations and ouabain on cardiac Na+, K+-ATPase and contractile force. J. Pharmacol. Exp. Ther. 197, 458–469 (1976)
Ku, D.D., Akera, T., Frank, M., Brody, T.M., Iwasa, J.: The effects of grayanotoxin I and a-dihydrograyanotoxin II on guinea pig myocardium. J. Pharmacol. Exp. Ther. 200, 363–372 (1977)
Ku, D.D., Akera, T., Olgaard, M.K., Brody, T.M.: Effects of lithium and thallous ions on sodium pump activity in the guinea-pig heart and their relationship to the positive isotropic action. Naunyn-Schmiedebergs Arch. Pharmacol. 304, 167–173 (1978)
Lahiri, A.K., Wilson, I.B.: On the inhibition of (Na++K+)-activated adenosine triphosphatase by diisopropyl fluorophosphate. Mol. Pharmacol. 7, 46–51 (1971)
Law, R.O.: The effects of ouabain and ethacrynic acid on the intracellular sodium and potassium concentrations in renal medullary slices incubated in cold potassium-free Ringer solution and re-incubated at 37°C in the presence of external potassium. J. Physiol. (Lond.) 254, 743–758 (1976)
Lee, K.S.: The metabolism and contraction of cat heart muscles as affected by drugs. J. Pharmacol. Exp. Ther. 112, 484–494 (1954)
Lee, K.S., Yu, D.H., Lee, D.I., Burstein, R.: The influence of potassium and calcium on the effect of ouabain on cat papillary muscles. J. Pharmacol. Exp. Ther. 132, 139–148 (1961)
Lee, C.Y., Chang, C.C., Chiu, T.H., Chiu, P.J.S., Tseng, T.C., Lee, S.Y.: Pharmacological properties of cardiotoxin isolated from Formosan cobra venom. Naunyn-Schmiedebergs Arch. Pharmacol. 259, 360–374 (1968)
Levi, R., Allan, G., Zavecz, J.H.: Cardiac histamine receptors. Fed. Proc. 35, 1942–1947 (1976)
Loewi, O.: On the mechanism of the positive inotropic action of fluoride, oleate, and calcium on the frog’s heart. J. Pharmacol. Exp. Ther. 114, 90–99 (1955)
Lowe, P.A., Wu, C.H., Narahashi, T.: The effect of anthopleurin-A on crayfish giant axon. J. Pharmacol. Exp. Ther. 210, 417–421 (1979)
Lowry, K., Rao, S.N., Pitts, B.J.R., Askari, A.: Effects of quinidine on some reactions and ion translocations catalyzed by the Na+, K+-ATPase complex. Biochem. Pharmacol. 22, 1369–1377 (1973)
Lüllmann, H., Holland, W.: Influence of ouabain on an exchangeable calcium fraction, contractile force, and resting tension of guinea-pig atria. J. Pharmacol. Exp. Ther. 137, 186–192 (1962)
Maling, H.M., Krayer, O.: The action of the erythrophleum alkaloids on the isolated mammalian heart. J. Pharmacol. Exp. Ther. 86, 66–78 (1946)
Matsui, H., Schwartz, A.: Purification and properties of a highly active, ouabain sensitive Na+-K+-dependent adenosine-triphosphatase from cardiac tissue. Biochim. Biophys. Acta 128, 380–390 (1966)
Miller, H.M., Woodhouse, S.P.: Long-chain fatty-acid inhibition of sodium plus potassium-activated adenosine-triphosphatase from rat heart. Aust. J. Exp. Biol. 55, 741–752 (1977)
Moran, N.C., Dresel, P.E., Perkins, M.E., Richardson, A.P.: The pharmacological actions of andromedotoxin, an active principle from Rhododendron Maximum. J. Pharmacol. Exp. Ther. 110, 415–432 (1954)
Myers, C.E., McGuire, W.P., Liss, R.H., Ifrim, I., Grotzinger, K., Young, R.C.: Adriamycin: The role of lipid peroxidation in cardiac toxicity and tumor response. Science 197, 165–167 (1977)
Narahashi, T., Seyama, I.: Mechanism of nerve membrane depolarization caused by grayanotoxin I. J. Physiol. (Lond.) 242, 471–487 (1974)
Narahashi, T., Albuquerque, E.X., Deguchi, T.: Effects of batrachotoxin on membrane potential and conductance of squid giant axons. J. Gen. Physiol. 58, 54–70 (1971)
Nechay, B.R., Saunders, J.P.: Inhibition of Na++K+-ATPase by vanadium pentoxide (V2O5). Fed. Proc. 37, 240 (1978)
Nix, C.R., Holland, W.C., Berry, R.A.: The action of cassaine and two of its alkylated derivatives on atrial contractions. Pharmacol. Res. Comm. 3, 75–78 (1971)
Ohta, M., Narahashi, T., Keeler, R.F.: Effects of veratrum alkaloids on membrane potential and conductance of squid and crayfish giant axons. J. Pharmacol. Exp. Ther. 184, 143–154 (1973)
Opit, L.J., Potter, H., Charnock, J.S.: The effect of anions on (Na+, K+)-activated ATPase. Biochim Biophys. Acta 120, 159–161 (1966)
Palatini, P.: The interaction of tricyclic antipsychotics with (Na+, K+)-ATPase. Gen. Pharmacol. 9, 215–220 (1978)
Penefsky, Z.J., Kahn, M.: Inotropic effects of dexamethasone in mammalian heart muscle. Eur. J. Pharmacol. 15, 259–266 (1971)
Penzotti, S.T., jr., Titus, E.: Evidence for two forms of fluoride-treated sodium-and potassium-dependent adenosine triphosphatase. Mol. Pharmacol. 8, 149–158 (1972)
Peters, T., Raben, R., Wassermann, O.: Evidence for a dissociation between positive inotropic effect and inhibition of the Na-K-ATPase by ouabain, cassaine and their alkylating derivatives. Eur. J. Pharmacol. 26, 166–174 (1974)
Phillips, T.D., Hayes, A.W., Ho, I.K., Desaiah, D.: Effects of rubratoxin-B on kinetics of cationic and substrate activation of (Na+-K+)-ATPase and paranitrophenyl phosphatase. J. Biol. Chem. 253, 3487–3493 (1978)
Pitts, B.J.R., Meyerson, L.R Inhibition of ouabain binding to Na,K-ATPase by sanguinarine: Correlation with the inotropic effect. Fed. Proc. 37, 240 (1978)
Ploeger, E.J.: The effects of lithium on excitable cell membranes. On the mechanism of inhibition of the sodium pump of non-myelinated nerve fibres of the rat. Eur. J. Pharmacol. 25, 316–321 (1974)
Post, R.L.: A model for regulation of vanadate inhibition of (Na, K)-ATPase by reduction. Fed. Proc. 38, 242 (1979)
Post, R.L., Kume, S., Tobin, T., Orcutt, B., Sen, A.K.: Flexibility of an active center in sodium plus potassium adenosine triphosphatase. J. Gen. Physiol. 54, 306s - 326s (1969)
Post, R.L., Hegyvary, C., Kume, S.: Activation by adenosine triphosphate in the phosphorylation kinetics of Na and K ion transport adenosine triphosphatase. J. Biol. Chem. 247, 6530–6540 (1972)
Prasad, K., Midha, K.K.: Effect of rubidium on cardiac function. Jpn. Heart J. 13, 317–324 (1972)
Pressman, B.C., Heeb, M.J.: Permeability studies on erythrocyte ghosts with ionophorous antibiotics. In: Munoz, E., Garcis-Fernandiz, F., Vasquez, D. (eds.), Molecular mechanisms of antibiotic action on protein biosynthesis and membranes, 3 ed., pp. 603–614. New York: Elsevier 1972
Pressman, B.C., DeGuzman, N.T., Somani, P.: Correlation of inotropic and transport properties of carboxylic ionophores. Pharmacologist 17, 245 (1975)
Prindle, K.H., jr., Gold, H.K., Cardon, P.V., Epstein, S.E.: Effects of pschychopharmacologic agents on myocardial contractility. J. Pharmacol. Exp. Ther. 173, 133–137 (1970)
Quist, E.E., Hokin, L.E.: The presence of two (Na, K)-ATPase inhibitors in equine muscle ATP: Vanadate and a dithioerythritol-dependent inhibitor. Biochim. Biophys. Acta 511, 202–212 (1978)
Ravens, U.: Electromechanical studies of an anemonia sulcata toxin in mammalian cardiac muscle. Naunyn-Schmiedebergs Arch. Pharmacol. 296, 73–78 (1976)
Reilly, J., Riker, W.F., jr., Whitehouse, W.C., Kuriaki, K.: The actions of methyl fluoroacetate on the papillary muscle of the cat with comparative experiments on the actions of methyl chloroacetate. J. Pharmacol. Exp. Ther. 108, 393–409 (1953)
Reiter, M.: The effect of various amines on the contractility of the guinea-pig papillary muscle. Experientia 21, 87–89 (1965)
Repke, K.: Über den biochemischen Wirkungsmodus von Digitalis. Klin. Wochenschr. 42, 157–165 (1964)
Repke, K., Portius, H.J.: Über die Identität der Ionenpumpen-ATPase in der Zellmembran des Herzmuskels mit einem Digitalis-Rezeptorenzym. Experientia 19, 452–458 (1963)
Riordan, J.R., Manery, J.F., Dryden, E.E., Still, J.S.: Influence of ethacrynic acid on muscle surface enzymes and of ethacrynic acid and ouabain on Na, K, and H2O in frog muscle. Can. J. Physiol. Pharmacol. 50, 432–444 (1972)
Robinson, J.D., Lowinger, J., Bettinger, B.: Chlorpromazine: Differential effects on mem- brane-bound enzyme from rat brain. Biochem. Pharmacol. 17, 1113–1116 (1968)
Romey, G., Abita, J.P., Schweitz, H., Wunderer, G., Lazdunski, M.: Sea anemone toxin: A tool to study molecular mechanisms of nerve conduction and excitation-secretion coupling. Proc. Natl. Acad. Sci. USA 73, 4055–4059 (1976)
Saunders, P.R., Sanyal, P.N.: Effect of temperature upon the positive inotropic action of ouabain. J. Pharmacol. Exp. Ther. 123, 161–163 (1958)
Schmitz, W., Hackbarth, I., Scholz, H.: Effect of vanadate on force of contraction in mammalian cardiac muscle. Naunyn-Schmiedebergs Arch. Pharmacol. 307, R37 (1979)
Schwabe, U., Puchstein, C., Hannemann, H., Söchtig, E.: Activation of adenylate cyclase by vanadate. Nature (Lond.) 277, 143–145 (1979)
Schwartz, A., Laseter, A.H.: A sodium-and potassium-stimulated adenosine triphosphatase from cardiac tissues. II. The effects of ouabain and other agents that modify enzyme activity. Biochem. Pharmacol. 13, 337–348 (1964)
Schwartz, A., Lindenmayer, G.E., Allen, J.C.: The sodium-potassium adenosine triphosphatase: Pharmacological, physiological, and biochemical aspects. Pharmacol. Rev. 27, 3–134 (1975)
Seifen, E., Straub, K.D.: Effects of sanguinarine on the isolated mammalian heart. Pharmacologist 16, 245 (1974)
Seyama, I.: Effect of grayanotoxin I on the electrical properties of rat skeletal muscle fibers. Jpn. J. Physiol. 20, 381–393 (1970)
Seyama, I., Narahashi, T.: Increase in sodium permeability of squid axon membranes by a-dihydrograyanotoxin II. J. Pharmacol. Exp. Ther. 184, 299–307 (1973)
Sharp, C.W., Hunt, H.G., Clements, S.T., Wilson, W.E.: The influence of dichlorodiphenyltrichloroethane, polychlorinated biphenyls, and anionic amphiphilic compounds on stabilization of sodium-and potassium-activated adenosine triphosphatase by acidic phospholipids. Mol. Pharmacol. 10, 119–129 (1974)
Shibata, S., Norton, T.R., Izumi, T., Matsuo, T., Katsuki, S.: A polypeptide (AP-A) from sea anemone (Anthopleura xanthogrammica) with potent positive inotropic action. J. Pharmacol. Exp. Ther. 199, 298–309 (1976)
Shibata, S., Izumi, T., Seriguchi, D.G., Norton, T.R.: Further studies on the positive inotropic effect of the polypeptide anthopleurin-A from a sea anemone. J. Pharmacol. Exp. Ther. 205, 683–692 (1978)
Shlafer, M., Matheny, J.L., Karow, M. jr.: Cardiac inotropism of dimethyl sulfoxide: Osmotic effects and interactions with calcium ion. Eur. J. Pharmacol. 28, 276–287 (1974)
Shlafer, M., Somani, P., Pressman, B.C., Palmer, R.F.: Effects of the carboxylic ionophore monensin on atrial contractility and Ca2+ regulation by isolated cardiac microsomes. J. Mol. Cell. Cardiol. 10, 333–346 (1978)
Shotzberger, G.S., Albuquerque, E.X., Daly, J.W.: The effects of batrachotoxin on cat papillary muscle. J. Pharmacol. Exp. Ther. 196, 433–444 (1976)
Siegel, G.J., Fogt, S.M.: Inhibition by lead ion of electrophorus electroplax (Na++K+)-adenosine triphosphatase and K+-p-nitrophenylphosphatase. J. Biol. Chem. 252, 5201–5205 (1977)
Skou, J.C.: The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochim. Biophys. Acta 23, 394–401 (1957)
Skou, J.C.: Further investigations on a Mg+++Na+-activated adenosine-triphosphatase, possibly related to the active, linked transport of Na+ and K+ across the nerve membrane. Biochim. Biophys. Acta 42, 6–23 (1960)
Skou, J.C.: Studies on the Na++K+ activated ATP hydrolyzing enzyme system. The role of SH groups. Biochem. Biophys. Res. Comm 10, 79–84 (1963)
Skou, J.C., Hilberg, C.: The effect of sulphydryl blocking reagents and of urea on the (Na+ + K+)-activated enzyme system. Biochim. Biophys. Acta 110, 359–369 (1965)
Skulskii, I.A., Manninen, V., Järnefelt, J: Thallium inhibition of ouabain-sensitive sodium transport and of the (Na+, K+)-ATPase in human erythrocytes. Biochim. Biophys. Acta 394, 569–576 (1975)
Somogyi, J.: Über die Wirkung der Ca-ionen auf die durch Na und K aktivierbare Adenosintriphosphatase des Hirngewebes. Hoppe-Seylers Z. Physiol. Chem. 336, 264–270 (1964)
Song, S.Y., Scheuer, J.: The effect of pharmacologic agents on myocardial sodium (Na+) and potassium (K+) stimulated ATPase. Pharmacology 1, 209–217 (1968)
Squires, R.F.: On the interaction of Na+, K+, Mg++, and ATP with the Na+ plus K+ activated ATPase from rat brain. Biochem. Biophys. Res. Comm. 19, 27–32 (1965)
Sutko, J.L., Besch, J.R. jr., Bailey, J.C., Zimmerman, G., Watanabe, A.M.: Direct effects of the monovalent cation ionophores monensin and nigericin on myocardium. J. Pharmacol. Exp. Ther. 203, 685–700 (1977)
Swanson, P.D.: Temperature dependence of sodium ion activation of the cerebral microsomal adenosine triphosphatase. J. Neurochem. 13, 229–236 (1966)
Szekeres, L., Papp, J.G., Udvary, E.: On two new isoquinoline derivatives with marked anti-anginal and antiarrhythmic actions. Naunyn-Schmiedebergs Arch. Pharmacol. 284, R79 (1974)
Tanaka, M., Hanin, M., Yasunobu, K.T., Norton, T.R.: Amino acid sequence of Anthopleura xanthogrammica heart stimulant, anthopleurin-A. Biochemistry 16, 204–208 (1977)
Taylor, S.R.: The effect of mercurial diuretics on ATPase of rabbit kidney in vitro. Biochem. Pharmacol. 12, 539–550 (1963)
Temma, K., Akera, T., Brody, T.M.: Hydroxylated chlorpromazine metabolites: Positive inotropic action and the release of catecholamines. Mol. Pharmacol. 13, 1076–1085 (1977)
Temma, K., Akera, T., Ku, D.D., Brody, T.M.: Sodium pump inhibition by sulfhydryl inhibitors and myocardial contractility. Naunyn-Schmiedebergs Arch. Pharmacol. 302, 63–71 (1978)
Tobin, T., Akera, T.: Showdomycin, a nucleotide-site-directed inhibitor of (Na++K+)ATPase. Biochim. Biophys. Acta 389, 126–136 (1975)
Tobin, T., Akera, T., Baskin, Si, Brody, T.M.: Calcium ion and sodium-and potassium-dependent adenosine triphosphatase: Its mechanism of inhibition and identification of the E1-P intermediate. Mol. Pharmacol. 9, 336–349 (1973)
Tobin, T., Akera, T., Dworin, J.Z., Brody, T.M.: Fluoride nephropathy: Lack of direct involvement of renal ATPase. Can. J. Physiol. Pharmacol. 52, 489–495 (1974a)
Tobin, T., Akera, T., Han, C.S., Brody, T-M.: Lithium and rubidium interactions with sodium-and potassium-dependent adenosine triphosphatase: A molecular basis for the pharmacological actions of these ions. Mol. Pharmacol. 10, 501–508 (1974b)
Tobin, T., Akera, T., Brody, S.L., Ku, D., Brody, T.M.: Cassaine: Mechanism of inhibition of Na++K+-ATPase and relationship of this inhibition to cardiotonic actions. Eur. J. Pharmacol. 32, 133–145 (1975)
Tobin, T., Akera, T., Han, C.S., Brody, T.M.: Studies on the stable inhibition of Na+, K+-ATPase by cassaine. Eur. J. Pharmacol. 35, 59–68 (1976)
Toda, N., Konishi, N.: Effects of a sulfhydryl reagent, N-ethylmaleimide, on electrical and mechanical activities of isolated atria. Eur. J. Pharmacol. 7, 5–13 (1969)
Toro-Goyco, E., Rodriguez, M.B., Preston, A.M.: On the action of Δ 9-tetrahydrocannabinol as an inhibitor of sodium-and potassium-dependent adenosine triphosphatase. Mol. Pharmacol. 14, 130–137 (1978)
Tuttle, R.S., Witt, P.N., Farah, A.: Therapeutic and toxic effects of ouabain on K+ fluxes in rabbit atria. J. Pharmacol. Exp. Ther. 137, 24–30 (1962)
Van Boxtel, C.J., Olson, R.D., Boerth, R.C., Oates, J.A.: Doxorubicin: inotropic effects and inhibitory action on ouabain. J. Pharmacol. Exp. Ther. 207, 277–283 (1978)
Van Groningen, H.E.M., Slater, E.C.: The effect of oligomycin on the Na+, K+ -activated magnesium-ATPase of brain microsomes and erythrocyte membrane. Biochim. Biophys. Acta 73, 527–530 (1963)
Vincent, J.P., Schweitz, H., Chicheportiche, R., Fosset, M., Balerna, M., Lenoir, M.C., Lazdunski, M.: Molecular mechanism of cardiotoxin action on axonal membranes. Biochemistry 15, 3171–3175 (1976)
Werdan, K., Bozsik, M., Erdmann, E., Krawietz, W., Schmitz, W., Scholz, H.: Vanadataufnahme und Vanadatwirkung in kultivierten, kontrahierenden Rattenherzmuskelzellen. Z. Kardiol. 68, 244 (1979)
Whittam, R., Wheeler, K.P., Blake, A.: Oligomycin and active transport reactions in cell membranes. Nature (Lond.) 203, 720–724 (1964)
Willis, J.S., Fang, L.S.T.: Li+ stimulation of ouabain-sensitive respiration and (Na+, K+)-ATPase of kidney cortex of ground squirrels. Biochim. Biophys. Acta 219, 486–489 (1970)
Wunderer, G., Fritz, H., Wachter, E., Machleidt, W.: Amino-acid sequence of a coelenterate toxin: Toxin II from Anemonia sulcata. Eur. J. Biochem. 68, 193–198 (1976)
Yamamoto, H.: Pharmacological studies on thiamine triphosphate. Folia Pharmacol. Jpn. 63, 134–152 (1967)
Yamamoto, H., Kitano, T., Nishino, H., Murano, T.: Studies on pharmacodynamic action of N-ethylmaleimide (NEM). I.: Influence of NEM on synaptic transmission of sympathetic nerves in guinea-pigs. Jpn. J. Pharmacol. 23, 151–160 (1973)
Yamamoto, S.: Prednisolone-3,20-bisguanylhydrazone: The mode of interaction with rat brain sodium and potassium-activated adenosine triphosphatase. Eur. J. Pharmacol. 50, 409–418 (1978)
Yamamoto, S., Akera, T., Brody, T.M.: Prednisolone-3,20-bisguanylhydrazone: Na+, K+-ATPase inhibition and positive inotropic action. Eur. J. Pharmacol. 49, 121–132 (1978a)
Yamamoto, S., Akera, T., Brody, T.M.: Prednisolone-3,20-bisguanylhydrazone: Binding in vitro to sodium-and potassium-activated adenosine triphosphatase of guinea-pig heart ventricular muscle. Eur. J. Pharmacol. 51, 63–69 (1978b)
Yoshida, H., Nagai, K., Kamei, M., Nakagawa, Y.: Irreversible inactivation of (Na++K+)-dependent ATPase and K+ -dependent phosphatase by fluoride. Biochim. Biophys. Acta 150, 162–164 (1968)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Akera, T., Fox, A.L., Greeff, K. (1981). Substances Possessing Inotropic Properties Similar to Cardiac Glycosides. In: Greeff, K. (eds) Cardiac Glycosides. Handbook of Experimental Pharmacology, vol 56 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68163-9_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-68163-9_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68165-3
Online ISBN: 978-3-642-68163-9
eBook Packages: Springer Book Archive